These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1555 related items for PubMed ID: 24387827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
    Gupta RT, Faridi KF, Singh AA, Passoni NM, Garcia-Reyes K, Madden JF, Polascik TJ.
    Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multiparametric magnetic resonance imaging localizes established extracapsular extension of prostate cancer.
    Feng TS, Sharif-Afshar AR, Smith SC, Miller J, Nguyen C, Li Q, Luthringer D, Li D, Saouaf R, Kim HL.
    Urol Oncol; 2015 Mar; 33(3):109.e15-22. PubMed ID: 25512160
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
    Somford DM, Hamoen EH, Fütterer JJ, van Basten JP, Hulsbergen-van de Kaa CA, Vreuls W, van Oort IM, Vergunst H, Kiemeney LA, Barentsz JO, Witjes JA.
    J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic accuracy of multiparametric magnetic resonance imaging in detecting extracapsular extension in intermediate and high - risk prostate cancer.
    Dominguez C, Plata M, Cataño JG, Palau M, Aguirre D, Narvaez J, Trujillo S, Gómez F, Trujillo CG, Caicedo JI, Medina C.
    Int Braz J Urol; 2018 Nov; 44(4):688-696. PubMed ID: 29570254
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
    Radtke JP, Hadaschik BA, Wolf MB, Freitag MT, Schwab C, Alt C, Roth W, Duensing S, Pahernik SA, Roethke MC, Schlemmer HP, Hohenfellner M, Teber D.
    J Endourol; 2015 Dec; 29(12):1396-405. PubMed ID: 26154571
    [Abstract] [Full Text] [Related]

  • 10. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer.
    Kim CK, Park SY, Park JJ, Park BK.
    AJR Am J Roentgenol; 2014 Mar; 202(3):W270-6. PubMed ID: 24555624
    [Abstract] [Full Text] [Related]

  • 11. Prostate cancer: utility of diffusion-weighted imaging as a marker of side-specific risk of extracapsular extension.
    Rosenkrantz AB, Chandarana H, Gilet A, Deng FM, Babb JS, Melamed J, Taneja SS.
    J Magn Reson Imaging; 2013 Aug; 38(2):312-9. PubMed ID: 23238968
    [Abstract] [Full Text] [Related]

  • 12. Incremental value of magnetic resonance imaging for clinically high risk prostate cancer in 922 radical prostatectomies.
    Jeong IG, Lim JH, You D, Kim MH, Choi HJ, Kim JK, Cho KS, Hong JH, Ahn H, Kim CS.
    J Urol; 2013 Dec; 190(6):2054-60. PubMed ID: 23791890
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
    Lista F, Andrés G, Cáceres F, Ramón de Fata F, Rodríguez-Barbero JM, Angulo JC.
    Actas Urol Esp; 2013 Dec; 37(7):419-24. PubMed ID: 23773823
    [Abstract] [Full Text] [Related]

  • 14. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy.
    Salonia A, Gallina A, Briganti A, Zanni G, Suardi N, Capitanio U, Colombo R, Bertini R, Freschi M, Guazzoni G, Rigatti P, Montorsi F.
    BJU Int; 2011 Apr; 107(8):1243-9. PubMed ID: 20883480
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development and internal validation of a side-specific, multiparametric magnetic resonance imaging-based nomogram for the prediction of extracapsular extension of prostate cancer.
    Martini A, Gupta A, Lewis SC, Cumarasamy S, Haines KG, Briganti A, Montorsi F, Tewari AK.
    BJU Int; 2018 Dec; 122(6):1025-1033. PubMed ID: 29676063
    [Abstract] [Full Text] [Related]

  • 17. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A, Nakashima J, Horiguchi Y, Nakagawa K, Oya M, Ohigashi T, Marumo K, Murai M.
    Prostate; 2003 Jun 15; 56(1):23-9. PubMed ID: 12746843
    [Abstract] [Full Text] [Related]

  • 18. Concordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patients.
    Nepple KG, Rosevear HM, Stolpen AH, Brown JA, Williams RD.
    Urol Oncol; 2013 Jul 15; 31(5):601-6. PubMed ID: 21665495
    [Abstract] [Full Text] [Related]

  • 19. The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.
    D'Amico AV, Whittington R, Schnall M, Malkowicz SB, Tomaszewski JE, Schultz D, Wein A.
    Cancer; 1995 May 01; 75(9):2368-72. PubMed ID: 7536124
    [Abstract] [Full Text] [Related]

  • 20. Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score.
    Naiki T, Okamura T, Nagata D, Mori Y, Kawai N, Ogawa K, Akita H, Hashimoto Y, Tozawa K, Kohri K.
    Asian Pac J Cancer Prev; 2011 May 01; 12(4):909-13. PubMed ID: 21790224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 78.